Academic Journals By Erika Lietzan
Access Before Evidence and the Price of FDA’s New Drug Authorities, 53 UNIVERSITY OF RICHMOND LAW REVIEW 1243 (2019).
Access Publication:
Access Before Evidence and the Price of FDA’s New Drug Authorities, 53 UNIVERSITY OF RICHMOND LAW REVIEW 1243 (2019).
Access Publication: